|1.||Chun, Jerold: 27 articles (02/2014 - 06/2002)|
|2.||Aoki, Junken: 25 articles (02/2015 - 07/2002)|
|3.||Fukushima, Nobuyuki: 18 articles (08/2014 - 06/2002)|
|4.||Ueda, Hiroshi: 18 articles (01/2014 - 01/2006)|
|5.||Mills, Gordon B: 18 articles (02/2013 - 05/2002)|
|6.||Tsujiuchi, Toshifumi: 16 articles (08/2014 - 05/2008)|
|7.||Xu, Yan: 15 articles (09/2015 - 09/2002)|
|8.||Morris, Andrew J: 14 articles (03/2014 - 03/2003)|
|9.||Arai, Hiroyuki: 14 articles (02/2008 - 07/2002)|
|10.||Fang, Xianjun: 13 articles (09/2015 - 05/2002)|
08/01/2009 - "To observe the effect of lysophosphatidic acid on cervical cancer cell line HeLa cells proliferation, adhesion, migration and apoptosis and study related signaling pathway. "
06/20/2014 - "Inactivation of INPP1 leads to a reduction in glycolytic intermediates that feed into the synthesis of the oncogenic signaling lipid lysophosphatidic acid (LPA), which in turn impairs LPA signaling and further attenuates glycolytic metabolism in a feed-forward mechanism to impair cancer cell motility, invasiveness, and tumorigenicity. "
01/01/2014 - "Lysophosphatidic acid (LPA) is involved in a number of biological processes, and may have a role in cancer cell migration and invasiveness. "
11/01/2013 - "Lysophosphatidic acid (LPA) is a lysophospholipid that mediates multiple behaviors in cancer cells, such as proliferation, migration and adhesion. "
10/01/2013 - "Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression."
01/01/2014 - "Recent studies indicate that lysophosphatidic acid (LPA) is also significantly involved in wound healing and the development of fibrosis. "
12/01/2010 - "This study was designed to determine: (i) whether fibroblasts isolated from skin of patients with SSc have increased lysophosphatidic acid-activated Cl- current (IClLPA) activity vs healthy controls; (ii) whether myofibroblast differentiation is involved in SSc skin fibrosis; and (iii) whether SSc fibroblasts have different proliferation rates vs controls. "
09/01/2014 - "Lysophosphatidic acid (LPA) and LPA1/3 plays a role in lung fibrosis. "
01/01/2014 - "Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts."
10/01/2013 - "Development of lysophosphatidic acid pathway modulators as therapies for fibrosis."
12/01/2009 - "In this study, we have focused on the negative regulation of lysophosphatidic acid (LPA)-induced migration in glioma cells. "
05/01/2005 - "We studied pathways involved in the proliferation of rat C6 glioma cells induced by lysophosphatidic acid (LPA), a phospholipid with diverse biological functions. "
05/01/2005 - "Signal transduction mechanisms involved in the proliferation of C6 glioma cells induced by lysophosphatidic acid."
03/01/2000 - "Role of lysophosphatidic acid and rho in glioma cell motility."
01/01/1997 - "Lysophosphatidic acid depletes intracellular calcium stores different from those mediating capacitative calcium entry in C6 rat glioma cells."
01/01/2002 - "Several studies have shown that lysophosphatidic acid (LPA), a phospholipidic chemical mediator, is relevant to the pathogenesis of ovarian carcinoma. "
09/04/2015 - "Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma."
01/01/2009 - "Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis."
05/21/2003 - "Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells."
04/01/2003 - "Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1."
12/01/2015 - "In this present study, we hypothesize that lysophosphatidic acid (LPA) mediates NKT cell activation in a mouse model of hyperoxic lung injury. "
09/04/2009 - "Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury."
12/01/2015 - "Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury."
03/01/2014 - "Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control study."
03/01/2012 - "Lysophosphatidic acid (LPA), which we have previously demonstrated to mediate bleomycin lung injury-induced fibroblast recruitment and vascular leak in mice and fibroblast recruitment in patients with IPF, is an important regulator of survival and apoptosis in many cell types. "
|1.||Platelet Activating Factor
|3.||Ethyl Ether (Ether)
|10.||Caspase 3 (Caspase-3)
|3.||Heterologous Transplantation (Xenotransplantation)